baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out AMGN/ DE000UH2DMN4 /

5/10/2024 9:49:37 PM	Chg.-0.030	Bid10:00:13 PM	Ask10:00:13 PM	Underlying	Strike price	Expiration date	Option type
0.990EUR	-2.94%	- Bid Size: -	- Ask Size: -	Amgen Inc	204.4553 USD	12/31/2078	Call

GlobeNewswire 5/9 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 5/9 argenx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 5/8 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

TeleTrader 5/8 US closes flat to higher with more earnings on the horizon

GlobeNewswire 5/8 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

TeleTrader 5/3 US closes higher after softer-than-expected jobs print

TeleTrader 5/3 Wall Street surges on open as jobs report sparks rate cut hopes

TeleTrader 5/3 Amgen soars 14% on positive weight-loss drug data

TeleTrader 5/2 Amgen Q1 revenue jumps 22% to $7.4 billion

TeleTrader 5/2 US surges at close as traders weigh Fed remarks

TeleTrader 5/2 US opens higher, Dow jumps 240 points

GlobeNewswire 5/2 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...

TeleTrader 5/2 US higher premarket after Fed's decision

GlobeNewswire 5/1 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...

GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 4/30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...

GlobeNewswire 4/24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...

TeleTrader 4/24 Wall Street opens mostly higher amid earnings jitters

GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 4/16 Turnstone Biologics Appoints William Waddill to its Board of Directors

GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 4/15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

GlobeNewswire 4/15 Shah Capital nominates two highly qualified independent director candidates for Novavax

UBS Knock-Out AMGN/ DE000UH2DMN4 /

If you wish to receive reply to your feedback, please provide your email address.